Help me with assessment for hirsutism with hypothyroidism and irregular menstrual cycle
Reading Document
Medical Text Search
hirsutism assessment clinical evaluation Ferriman-Gallwey score causes differential diagnosis
Medical Text Search
hirsutism hypothyroidism irregular menstrual cycle anovulation hormonal workup investigations
GradeResponse
GradeResponse
Here is a comprehensive assessment framework for hirsutism presenting with hypothyroidism and irregular menstrual cycle:
Assessment of Hirsutism with Hypothyroidism and Irregular Menstrual Cycle
1. Understanding the Clinical Triad
This combination — hirsutism + hypothyroidism + irregular menstrual cycles — represents a hyperandrogenic endocrine disorder picture. These three features together mandate a full endocrine workup. Hypothyroidism itself can cause anovulation and menstrual irregularity, but it must be distinguished from coexisting or independent causes of androgen excess.
2. History Taking
Menstrual History
- Age of menarche
- Cycle length, regularity, duration, flow
- Oligomenorrhea (cycles >35 days) vs. amenorrhea vs. polymenorrhea
- Infertility concerns
Hirsutism History
- Age of onset — pubertal (congenital adrenal hyperplasia, PCOS) vs. adult onset (tumor, Cushing's)
- Rate of progression — sudden onset or rapid progression raises concern for an androgen-secreting tumor
- Distribution — male-pattern (androgen-driven) vs. generalized (drug-induced, familial)
- Hair removal methods in use (may mask severity)
Hypothyroid Symptoms
- Weight gain, cold intolerance, fatigue, constipation, dry skin, hair thinning/loss, bradycardia, delayed reflexes
- Known thyroid disease, prior thyroid surgery, radioiodine therapy
- Family history of autoimmune thyroid disease
Drug History
Drugs that can cause hirsutism:
- Anabolic/androgenic steroids
- Valproic acid
- Danazol, progestins with androgenic activity
- Minoxidil, cyclosporine
Family & Ethnic Background
- Important for Ferriman-Gallwey score interpretation (see below)
- Family history of PCOS, CAH, thyroid disease
3. Physical Examination
Ferriman-Gallwey (mFG) Scoring
Assess terminal hair in 9 androgen-sensitive body areas, each scored 0–4:
| Body Area | Score 0–4 |
|---|---|
| Upper lip | |
| Chin | |
| Chest | |
| Upper abdomen | |
| Lower abdomen | |
| Upper back | |
| Lower back | |
| Upper arm | |
| Thigh |
Thresholds for hirsutism (Endocrine Society guidelines):
| Population | Hirsutism threshold |
|---|---|
| US/UK Black or White women | mFG ≥ 8 |
| Mediterranean / Hispanic / Middle Eastern | mFG ≥ 9–10 |
| South American | mFG ≥ 6 |
| Han Chinese women | mFG ≥ 2 |
| Southern Chinese women | mFG ≥ 7 |
(Evaluation and Treatment of Hirsutism in Premenopausal Women, p. 5)
Note: The mFG score does not capture sideburns or buttocks — locally high scores in those areas may not elevate the total but are still clinically relevant.
Signs of Hyperandrogenism
- Acne (comedonal, papular, nodular)
- Androgenic alopecia (male-pattern hair thinning at vertex/frontal)
- Virilization (clitoromegaly, deepening voice, increased muscle mass) → suggests severe androgen excess, possibly tumor
Signs of Associated Endocrine Disorders
| Disorder | Signs to Seek |
|---|---|
| Hypothyroidism | Dry skin, coarse hair, periorbital puffiness, goiter, bradycardia, delayed relaxation of reflexes, weight gain |
| PCOS | Central obesity, acanthosis nigricans, polycystic ovaries |
| Cushing syndrome | Central obesity, moon facies, buffalo hump, striae, easy bruising, proximal myopathy, hypertension |
| Acromegaly | Enlarged hands/feet, coarse facies, prognathism, macroglossia |
| Androgen-secreting tumor | Rapidly progressive virilization, very high androgens |
| Non-classic CAH (NCCAH) | Pubertal-onset hirsutism, family history (Ashkenazi Jewish, Hispanic, Slavic heritage at higher risk) |
4. Investigations
Step 1: Confirm and Characterize Hypothyroidism
- TSH (first-line) — elevated TSH confirms primary hypothyroidism
- Free T4 — to assess severity
- Anti-TPO antibodies — if Hashimoto's thyroiditis suspected
- Anti-thyroglobulin antibodies — if anti-TPO negative but clinical suspicion high
Hypothyroidism causes elevated TRH → elevated prolactin → anovulation and menstrual irregularity. It can also directly suppress SHBG, increasing free androgen levels and contributing to hirsutism.
Step 2: Androgen Testing
(Evaluation and Treatment of Hirsutism in Premenopausal Women, p. 8)
Preferred timing: Early morning, days 4–10 of the menstrual cycle (when ovarian follicle development is most comparable to hyperandrogenic anovulation).
| Test | When to Order | Notes |
|---|---|---|
| Serum total testosterone | All women with hirsutism + clinical signs of hyperandrogenic disorder | Best measured by mass spectrometry for accuracy |
| Serum free testosterone | Moderate/severe hirsutism with normal total T; or clinical PCOS | Most clinically sensitive single marker of androgen excess |
| SHBG | Alongside free T | Reduced SHBG (e.g., from hypothyroidism, insulin resistance, obesity) increases bioavailable androgens |
| DHEAS | If adrenal source suspected | Elevated in adrenal tumors, CAH |
| 17-hydroxyprogesterone (17-OHP) | Early morning (follicular phase) | Rule out non-classic CAH; if borderline, proceed to ACTH stimulation test |
Action thresholds:
- Total testosterone > 200 ng/dL (6.9 nmol/L) → high suspicion for androgen-secreting tumor → imaging
- Total testosterone > 150 ng/dL → DHEAS assay + pelvic/adrenal imaging
Step 3: Evaluate for PCOS
PCOS is the most common hyperandrogenic endocrine disorder associated with hirsutism. After excluding thyroid disease and other causes:
Apply Rotterdam criteria (2 of 3 required):
- Oligo/anovulation
- Clinical or biochemical hyperandrogenism
- Polycystic ovarian morphology on ultrasound
Additional tests:
- LH:FSH ratio (often elevated in PCOS, though not diagnostic)
- Fasting glucose and insulin / HOMA-IR (assess insulin resistance)
- Fasting lipid profile (metabolic syndrome screen)
- Pelvic ultrasound — polycystic ovary morphology (≥12 follicles per ovary 2–9 mm in diameter, or ovarian volume >10 mL)
Step 4: Rule Out Other Causes
| Condition | Key Tests |
|---|---|
| Non-classic CAH | Early-morning 17-OHP (follicular phase); if ≥ 2 ng/mL → ACTH stimulation test |
| Cushing syndrome | 24-hour urinary free cortisol; overnight 1 mg dexamethasone suppression test; late-night salivary cortisol |
| Hyperprolactinemia | Serum prolactin (check — hypothyroidism itself raises prolactin) |
| Androgen-secreting tumor | DHEAS, testosterone; pelvic/adrenal imaging if very high androgens or rapid virilization |
| Acromegaly | IGF-1, GH after oral glucose load (if clinically suspected) |
Summary Investigation Panel
| Category | Tests |
|---|---|
| Thyroid | TSH, Free T4, Anti-TPO |
| Androgens | Total testosterone (mass spec), free testosterone, SHBG, DHEAS |
| Adrenal | 17-OHP (early morning, follicular phase) |
| Prolactin | Serum prolactin |
| PCOS screen | LH, FSH, fasting glucose, fasting insulin, lipid panel |
| Imaging | Pelvic ultrasound (ovarian morphology) ± adrenal CT/MRI if tumor suspected |
| Cushing screen | If clinically indicated: 24h UFC or overnight DST |
5. Differential Diagnosis
| Cause | Key Features |
|---|---|
| PCOS | Most common; oligomenorrhea, biochemical hyperandrogenism, polycystic ovaries |
| Hypothyroidism | Can cause anovulation and mildly elevated free androgens (via reduced SHBG); treat the thyroid first |
| Hyperprolactinemia | Can be secondary to hypothyroidism; causes anovulation, galactorrhea |
| Non-classic CAH | Pubertal/adult onset; elevated 17-OHP; high-risk ethnic groups |
| Cushing syndrome | Central obesity, striae, hypertension, glucose intolerance |
| Androgen-secreting tumor | Rapid virilization, very high testosterone or DHEAS |
| Idiopathic hirsutism | Normal androgens, regular cycles, normal ovarian morphology |
| Drug-induced | History of valproate, steroids, or testosterone-containing products |
6. Clinical Decision Algorithm
(Adapted from Evaluation and Treatment of Hirsutism in Premenopausal Women, p. 8)
Hirsutism + Menstrual Irregularity + Hypothyroid Features
↓
Confirm/treat hypothyroidism (TSH, Free T4)
↓
Is hypothyroidism the sole explanation? → Re-assess after euthyroidism
↓ (if persists or androgens elevated)
Measure Total Testosterone (early morning, days 4–10)
↓
Total T normal Total T > 150–200 ng/dL
↓ ↓
Free T + SHBG Imaging (ovarian/adrenal)
↓ + DHEAS, 17-OHP
Mild hirsutism Rule out tumor/CAH
+ normal ovaries
= Idiopathic hirsutism
↓
17-OHP (if NCCAH risk) → ACTH stimulation if elevated
↓
LH, FSH, ultrasound → PCOS evaluation
↓
Cortisol studies if Cushing suspected
Key Clinical Pearls
- Treat hypothyroidism first — correction of hypothyroidism may restore ovulatory cycles and reduce androgen availability (by normalizing SHBG), partially resolving hirsutism without additional intervention.
- Hypothyroidism → ↑TRH → ↑prolactin → anovulation; also ↓SHBG → ↑free testosterone — two independent mechanisms contributing to the triad.
- Sudden-onset or rapidly progressive hirsutism + virilization = androgen-secreting tumor until proven otherwise.
- PCOS and hypothyroidism are not mutually exclusive — both can coexist and reinforce each other.
- Idiopathic hirsutism is a diagnosis of exclusion: normal androgens, regular cycles, normal ovarian morphology.
This is a shared conversation. Sign in to Orris to start your own chat.